10 Questions
What is the recurrence rate of VTE in the first year for patients without identifiable transient risk factors?
10%
What is the recommended approach for anticoagulation in patients with a second unprovoked VTE?
Indefinite anticoagulation
What is the benefit of using low-dose apixaban or rivaroxaban in patients with unprovoked VTE?
Same efficacy with no significant increase in bleeding risk
What is the anticoagulant of choice for cancer patients with VTE?
LMWH (e.g. enoxaparin)
Why are cancer patients more likely to die from VTEs?
Due to complications and increased risk of VTEs
What is the recommended anticoagulation approach for patients with cancer-associated thrombosis?
Indefinite anticoagulation unless cure is achieved
Why are pregnant women at increased risk of VTEs?
Due to venous stasis, endothelial injury, and hypercoagulability
What is the anticoagulant of choice during pregnancy and breastfeeding?
LMWH (e.g. enoxaparin)
What is the benefit of using apixaban or rivaroxaban in cancer patients with VTEs?
Possible higher bleeding risk in GI cancer
What is the goal of extended anticoagulation beyond 3-6 months in patients with unprovoked VTE?
To reduce the risk of recurrence
Test your knowledge on the types of bleeding events associated with haemophilia, including haemarthrosis, muscle bleeding, and mucous membrane bleeding. Also, learn about the classification of haemophilia based on factor levels.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
